Skip to main content
Top
Published in: Infection 6/2017

01-12-2017 | Original Paper

Bacterial meningitis complicating the course of liver cirrhosis

Authors: Pasquale Pagliano, Giovanni Boccia, Francesco De Caro, Silvano Esposito

Published in: Infection | Issue 6/2017

Login to get access

Abstract

Summary

Meningitis is rarely reported in studies investigating bacterial infections in patients affected by liver cirrhosis. We investigated the findings of bacterial meningitis in patients affected by liver cirrhosis referred to our department in a 16-year period.

Materials

Patients with cirrhosis and bacterial meningitis were enrolled. Cirrhosis was defined by liver histology or clinical, laboratory, and ultrasonographic and endoscopic findings. Bacterial meningitis was defined by cerebro-spinal fluid pleocytosis (>10/mcl) and characteristic clinical presentation. Fisher exact test and Wilcoxon rank-sum test were employed as appropriate for statistical analysis.

Results

Forty-four patients with bacterial meningitis and cirrhosis were enrolled in the study. Sex ratio (male:female) was 1.4:1 and median (IQR) age was 64 (55–72) years. Cirrhosis was viral in 40 patients. At admission, median (IQR) MELD score was 12 (9–14), and median (IQR) Child-Pugh score was 8 (6–10). Other conditions associated with immunodepression were present in 22 (50%) cases. Streptococcus pneumoniae and Listeria monocytogenes were the agents more frequently identified. An extra-meningeal focus of infection was identified in 17 (39%) cases. Main symptoms at admission were fever, nuchal rigidity, and an obtunded or comatose status, and at least 2 of these were reported in 37 (84%) episodes. Cerebro-spinal fluid showed high cells, low CSF/serum glucose ratio, and elevated protein. Seventeen patients (39%) died and 8 (18%) reported sequelae. High MELD and Child-Pugh scores were related to the mortality risk (p < 0.001). The findings of blood and cerebro-spinal fluid analysis were not predictive of outcome.

Conclusions

Bacterial meningitis should be considered in cirrhotics presenting with fever and altered conscience status. MELD and Child-Pugh scores predicted prognosis.
Literature
1.
go back to reference Garcia-Tsao G. Bacterial infections in cirrhosis: treatment and prophylaxis. J Hepatol. 2005;42:S85–92.CrossRefPubMed Garcia-Tsao G. Bacterial infections in cirrhosis: treatment and prophylaxis. J Hepatol. 2005;42:S85–92.CrossRefPubMed
2.
go back to reference Dionigi E, Garcovich M, Borzio M, et al. Bacterial infections change natural history of cirrhosis irrespective of liver disease severity. Am J Gastroenterol. 2017. doi:10.1038/ajg.2017.19.PubMed Dionigi E, Garcovich M, Borzio M, et al. Bacterial infections change natural history of cirrhosis irrespective of liver disease severity. Am J Gastroenterol. 2017. doi:10.​1038/​ajg.​2017.​19.PubMed
3.
go back to reference Tritto G, Bechlis Z, Stadlbauer V, et al. Evidence of neutrophil functional defect despite inflammation in stable cirrhosis. J Hepatol. 2011;55:574–81.CrossRefPubMed Tritto G, Bechlis Z, Stadlbauer V, et al. Evidence of neutrophil functional defect despite inflammation in stable cirrhosis. J Hepatol. 2011;55:574–81.CrossRefPubMed
4.
go back to reference Horvath A, Leber B, Schmerboeck B, et al. Randomised clinical trial: the effects of a multispecies probiotic vs. placebo on innate immune function, bacterial translocation and gut permeability in patients with cirrhosis. Aliment Pharmacol Ther. 2016;44:926–35.CrossRefPubMedPubMedCentral Horvath A, Leber B, Schmerboeck B, et al. Randomised clinical trial: the effects of a multispecies probiotic vs. placebo on innate immune function, bacterial translocation and gut permeability in patients with cirrhosis. Aliment Pharmacol Ther. 2016;44:926–35.CrossRefPubMedPubMedCentral
5.
go back to reference Brandolini M, Corbella M, De Silvestri A, et al. Epidemiological characteristics of bloodstream infections in patients with different degrees of liver disease. Infection. 2015;43:561–7.CrossRefPubMed Brandolini M, Corbella M, De Silvestri A, et al. Epidemiological characteristics of bloodstream infections in patients with different degrees of liver disease. Infection. 2015;43:561–7.CrossRefPubMed
6.
7.
go back to reference Pagliano P, Costantini S, Gradoni L, et al. Distinguishing visceral leishmaniasis from intolerance to pegylated interferon-alpha in a thalassemic splenectomized patient treated for chronic hepatitis C. Am J Trop Med Hyg. 2008;79:9–11.PubMed Pagliano P, Costantini S, Gradoni L, et al. Distinguishing visceral leishmaniasis from intolerance to pegylated interferon-alpha in a thalassemic splenectomized patient treated for chronic hepatitis C. Am J Trop Med Hyg. 2008;79:9–11.PubMed
8.
go back to reference Tandon P, Garcia-Tsao G. Bacterial infections, sepsis, and multiorgan failure in cirrhosis. Semin Liver Dis. 2008;28:26–42.CrossRefPubMed Tandon P, Garcia-Tsao G. Bacterial infections, sepsis, and multiorgan failure in cirrhosis. Semin Liver Dis. 2008;28:26–42.CrossRefPubMed
9.
go back to reference Cabellos C, Viladrich PF, Ariza J, et al. Community-acquired bacterial meningitis in cirrhotic patients. Clin Microbiol Infect. 2008;14:35–40.CrossRefPubMed Cabellos C, Viladrich PF, Ariza J, et al. Community-acquired bacterial meningitis in cirrhotic patients. Clin Microbiol Infect. 2008;14:35–40.CrossRefPubMed
10.
go back to reference Fernández J, Navasa M, Gómez J, et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology. 2002;35:140–8.CrossRefPubMed Fernández J, Navasa M, Gómez J, et al. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology. 2002;35:140–8.CrossRefPubMed
11.
go back to reference Cristou L, Pappas G, Falagas M. Bacterial infection-related morbidity and mortality in cirrhosis. Am J Gastroenterol. 2007;102:1510–7.CrossRef Cristou L, Pappas G, Falagas M. Bacterial infection-related morbidity and mortality in cirrhosis. Am J Gastroenterol. 2007;102:1510–7.CrossRef
12.
go back to reference Brouwer MC, Tunkel AR, van de Beek D. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev. 2010;23:467–92.CrossRefPubMedPubMedCentral Brouwer MC, Tunkel AR, van de Beek D. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev. 2010;23:467–92.CrossRefPubMedPubMedCentral
13.
go back to reference Lim S, Chung DR, Kim YS, et al. Predictive risk factors for Listeria monocytogenes meningitis compared to pneumococcal meningitis: a multicenter case–control study. Infection. 2017;45:67–74.CrossRefPubMed Lim S, Chung DR, Kim YS, et al. Predictive risk factors for Listeria monocytogenes meningitis compared to pneumococcal meningitis: a multicenter case–control study. Infection. 2017;45:67–74.CrossRefPubMed
14.
go back to reference Weissenborn K, Bokemeyer M, Krause J, Ennen J, Ahl B. Neurological and neuropsychiatric syndrome associated with liver disease. AIDS. 2005;19:S93–8.CrossRefPubMed Weissenborn K, Bokemeyer M, Krause J, Ennen J, Ahl B. Neurological and neuropsychiatric syndrome associated with liver disease. AIDS. 2005;19:S93–8.CrossRefPubMed
15.
go back to reference American Association for the Study of Liver, European Association for the Study of the Liver. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the European Association for the study of the liver and the American Association for the study of liverdiseases. J Hepatol. 2014;61:642–59.CrossRef American Association for the Study of Liver, European Association for the Study of the Liver. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the European Association for the study of the liver and the American Association for the study of liverdiseases. J Hepatol. 2014;61:642–59.CrossRef
16.
go back to reference Pagliano P, Attanasio V, Rossi M, et al. Pneumococcal meningitis in cirrhotics: distinctive findings of presentation and outcome. J Infect. 2012;65:577–9.CrossRefPubMed Pagliano P, Attanasio V, Rossi M, et al. Pneumococcal meningitis in cirrhotics: distinctive findings of presentation and outcome. J Infect. 2012;65:577–9.CrossRefPubMed
17.
go back to reference Sagnelli E, Stroffolini T, Mele A, et al. The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9,997 cases. J Med Virol. 2005;75:522–7.CrossRefPubMed Sagnelli E, Stroffolini T, Mele A, et al. The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9,997 cases. J Med Virol. 2005;75:522–7.CrossRefPubMed
18.
go back to reference Butterworth RF. The liver–brain axis in liver failure: neuroinflammation and encephalopathy. Nat Rev Gastroenterol Hepatol. 2013;10:522–8.CrossRefPubMed Butterworth RF. The liver–brain axis in liver failure: neuroinflammation and encephalopathy. Nat Rev Gastroenterol Hepatol. 2013;10:522–8.CrossRefPubMed
19.
go back to reference Shawcross DL, Davies NA, Williams R, Jalan R. Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol. 2004;40:247–54.CrossRefPubMed Shawcross DL, Davies NA, Williams R, Jalan R. Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol. 2004;40:247–54.CrossRefPubMed
20.
go back to reference Hackstein C, Assmus LM, Welz M, et al. Gut microbial translocation corrupts myeloid cell function to control bacterial infection during liver cirrhosis. Gut. 2017;66:507–18.CrossRefPubMed Hackstein C, Assmus LM, Welz M, et al. Gut microbial translocation corrupts myeloid cell function to control bacterial infection during liver cirrhosis. Gut. 2017;66:507–18.CrossRefPubMed
21.
go back to reference Bonnel AR, Bunchorntavakul C, Reddy KR. Immunedysfunction and infections in patients with cirrhosis. Clin Gastroenterol Hepatol. 2011;9:727–38.CrossRefPubMed Bonnel AR, Bunchorntavakul C, Reddy KR. Immunedysfunction and infections in patients with cirrhosis. Clin Gastroenterol Hepatol. 2011;9:727–38.CrossRefPubMed
22.
go back to reference Schrag SJ, Beall B, Dowell SF. Limiting the spread of resistant pneumococci: biological and epidemiologic evidence for the effectiveness of alternative interventions. Clin Microbiol Rev. 2000;13:588–601.CrossRefPubMedPubMedCentral Schrag SJ, Beall B, Dowell SF. Limiting the spread of resistant pneumococci: biological and epidemiologic evidence for the effectiveness of alternative interventions. Clin Microbiol Rev. 2000;13:588–601.CrossRefPubMedPubMedCentral
23.
go back to reference Lipsitch M. Measuring and interpreting associations between antibiotic use and penicillin resistance in Streptococcus pneumoniae. Clin Infect Dis. 2001;32:1044–54.CrossRefPubMed Lipsitch M. Measuring and interpreting associations between antibiotic use and penicillin resistance in Streptococcus pneumoniae. Clin Infect Dis. 2001;32:1044–54.CrossRefPubMed
24.
go back to reference Bouza E, Pintado V, Rivera S, et al. Nosocomial bloodstream infections caused by Streptococcus pneumoniae. Clin Microbiol Infect. 2005;11:919–24.CrossRefPubMed Bouza E, Pintado V, Rivera S, et al. Nosocomial bloodstream infections caused by Streptococcus pneumoniae. Clin Microbiol Infect. 2005;11:919–24.CrossRefPubMed
25.
go back to reference Pagliano P, Ascione T, Boccia G, De Caro F, Esposito S. Listeria monocytogenes meningitis in the elderly: epidemiological, clinical and therapeutic findings. Infez Med. 2016;24:105–11.PubMed Pagliano P, Ascione T, Boccia G, De Caro F, Esposito S. Listeria monocytogenes meningitis in the elderly: epidemiological, clinical and therapeutic findings. Infez Med. 2016;24:105–11.PubMed
26.
go back to reference Pagliano P, Attanasio V, Rossi M, et al. Listeria monocytogenes meningitis in the elderly: distinctive characteristics of the clinical and laboratory presentation. J Infect. 2012;71:134–6.CrossRef Pagliano P, Attanasio V, Rossi M, et al. Listeria monocytogenes meningitis in the elderly: distinctive characteristics of the clinical and laboratory presentation. J Infect. 2012;71:134–6.CrossRef
27.
go back to reference Arslan F, Meynet E, Sunbul M, et al. The clinical features, diagnosis, treatment, and prognosis of neuroinvasive listeriosis: a multinational study. Eur J Clin Microbiol Infect Dis. 2015;34:1213–21.CrossRefPubMed Arslan F, Meynet E, Sunbul M, et al. The clinical features, diagnosis, treatment, and prognosis of neuroinvasive listeriosis: a multinational study. Eur J Clin Microbiol Infect Dis. 2015;34:1213–21.CrossRefPubMed
28.
go back to reference Aronin SI, Peduzzi P, Quagliarello VJ. Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing. Ann Intern Med. 1998;129:862–9.CrossRefPubMed Aronin SI, Peduzzi P, Quagliarello VJ. Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing. Ann Intern Med. 1998;129:862–9.CrossRefPubMed
29.
go back to reference Auburtin M, Wolff M, Charpentier J, et al. Detrimental role of delayed antibiotic administration and penicillin-non susceptible strains in adult intensive care unit patients with pneumococcal meningitis: the PNEUMOREA prospective multicenter study. Crit Care Med. 2006;34:2758–65.CrossRefPubMed Auburtin M, Wolff M, Charpentier J, et al. Detrimental role of delayed antibiotic administration and penicillin-non susceptible strains in adult intensive care unit patients with pneumococcal meningitis: the PNEUMOREA prospective multicenter study. Crit Care Med. 2006;34:2758–65.CrossRefPubMed
30.
go back to reference van de Beek D, Cabellos C, Dzupova O, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016;22:S37–62.CrossRefPubMed van de Beek D, Cabellos C, Dzupova O, et al. ESCMID guideline: diagnosis and treatment of acute bacterial meningitis. Clin Microbiol Infect. 2016;22:S37–62.CrossRefPubMed
31.
go back to reference Attia J, Hatala R, Cook DJ, Wong JG. Does this adult patient have acute meningitis? JAMA. 1999;282:175–81.CrossRefPubMed Attia J, Hatala R, Cook DJ, Wong JG. Does this adult patient have acute meningitis? JAMA. 1999;282:175–81.CrossRefPubMed
32.
go back to reference Ray P, Badarou-Acossi G, Viallon A, et al. Accuracy of the cerebrospinal fluid results to differentiate bacterial from non bacterial meningitis, in case of negative gram-stained smear. Am J Emerg Med. 2007;2:179–84.CrossRef Ray P, Badarou-Acossi G, Viallon A, et al. Accuracy of the cerebrospinal fluid results to differentiate bacterial from non bacterial meningitis, in case of negative gram-stained smear. Am J Emerg Med. 2007;2:179–84.CrossRef
33.
go back to reference Weisfelt M, van de Beek D, Spanjaard L, Reitsma JB, de Gans J. A risk score for unfavourable outcome of adults with bacterial meningitis. Ann Neurol. 2007;63:90–7.CrossRef Weisfelt M, van de Beek D, Spanjaard L, Reitsma JB, de Gans J. A risk score for unfavourable outcome of adults with bacterial meningitis. Ann Neurol. 2007;63:90–7.CrossRef
34.
go back to reference Hoffmann O, Mahrhofer C, Rueter N, et al. Pneumococcal cell wall-induced meningitis impairs adult hippocampal neurogenesis. Infect Immun. 2007;75:4289–97.CrossRefPubMedPubMedCentral Hoffmann O, Mahrhofer C, Rueter N, et al. Pneumococcal cell wall-induced meningitis impairs adult hippocampal neurogenesis. Infect Immun. 2007;75:4289–97.CrossRefPubMedPubMedCentral
35.
go back to reference Méndez M, Méndez-López M, Lopez L, Aller MA, Arias J, Arias JL. Mammillary body alterations and spatial memory impairment in Wistar rats with thioacetamide-induced cirrhosis. Brain Res. 2008;1233:185.CrossRefPubMed Méndez M, Méndez-López M, Lopez L, Aller MA, Arias J, Arias JL. Mammillary body alterations and spatial memory impairment in Wistar rats with thioacetamide-induced cirrhosis. Brain Res. 2008;1233:185.CrossRefPubMed
Metadata
Title
Bacterial meningitis complicating the course of liver cirrhosis
Authors
Pasquale Pagliano
Giovanni Boccia
Francesco De Caro
Silvano Esposito
Publication date
01-12-2017
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 6/2017
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-017-1039-7

Other articles of this Issue 6/2017

Infection 6/2017 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.